|
|
|
|
|
|
|
|
ISCT 2026 is taking place May 6-9, 2026, in Dublin, Ireland. Join 3,000+ delegates from 60+ countries, including scientists, regulators, industry leaders, and clinicians, for the premier international meeting uniting the global leaders in cell and gene therapy translation to decide what comes next for the field. Learn more or register now
|
|
|
|
|
|
Video | Thermo Fisher Scientific Bioproduction
|
Learn about manufacturing solutions that streamline cell culture media scale-up with global production capabilities, equivalency strategies, and quality assurance for reliable supply.
|
|
|
|
|
|
Webinar | Lonza
|
Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies. Establish standards for every day, and continually work on improving operational excellence.
|
|
|
|
|
|
Video | Invetech
|
Discover how to deliver tailored, GMP-compliant automation solutions to your cell therapy manufacturing, which can accelerate innovation from process development to scalable production.
|
|
|
|
|
|
Video | Cell & Gene
|
In this segment from the Cell & Gene Live digital event “Stem-Cell Derived Therapies: From Source To Site,” we explore bit.bio’s approach to iPSC differentiation compared to traditional, directed differentiation.
|
|
|
|
|
|
Video | Cell & Gene
|
During this segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Senti Biosciences' Tim Lu, M.D., Ph.D. described how an AI-guided workflow at Senti optimized paired activating and inhibitory CAR designs, outperforming manually distinguishing cancer from healthy cells and accelerating lead selection.
|
|
|
|
|
|
Webinar | RoosterBio
|
EVs need established quality attributes. This webinar explores how analytical tools can assess the impact of production process choices and tissue source on the quality attributes of MSC-derived EVs.
|
|
|